Acro Biomedical Co., Ltd. Financial Ratios — ACBM Stock

Profitability (USD)

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	-197.41	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-271.48	-0.82	41.32	-29.05	-37.13	-12.17	-875.19	-2,191.34	-2,361.45	-93.54	-439.08
Return on Capital (%)	- -	- -	- -	167.69	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	41.78	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	10	10.4	10	6.25	23.17	21.67	21.34	- -	- -	- -
EBITDA Margin (%)	- -	- -	-0.44	6.43	-32.61	-218.44	-18.96	-642.47	-2,409.98	- -	- -	- -
Operating Margin (%)	- -	- -	-0.44	6.43	-32.61	-218.44	-18.96	-642.47	-2,409.98	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	6.9	- -	- -	- -	- -	- -	-1,074.77	- -	- -
Pretax Margin (%)	- -	- -	-0.44	6.39	-32.78	-219.46	-19.7	-642.82	-2,410.24	- -	- -	- -
Profit Margin (%)	- -	- -	-0.44	5.24	-27.38	-192.01	-17.07	-642.82	-2,410.24	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	-0.44	5.24	-27.38	-192.01	-17.07	-642.82	-2,410.24	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	18.02	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-197.41	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	-0.23	-16.18	0.27	- -	-0.11	-0.19	-0.01	- -	-0.01	-0.71	- -
Net Debt/EBITDA	0.57	-0.17	0.19	0.27	- -	- -	0.14	0.01	- -	- -	0.01	0.03
Total Debt/EBIT	- -	-0.23	-16.18	0.27	- -	-0.11	-0.19	-0.01	- -	-0.01	-0.71	- -
Net Debt/EBIT	0.57	-0.17	0.19	0.27	- -	- -	0.14	0.01	- -	- -	0.01	0.03
EBITDA to Interest Expense	- -	- -	- -	140.75	-194.95	-213.19	-25.67	-1,810.25	-9,302.31	-2,742.47	-8.75	-16.83
EBITDA-CapEx/Interest Expense	- -	- -	- -	140.75	-194.95	-213.19	-25.67	-1,810.25	-9,302.31	-2,742.47	-8.75	-16.83
EBIT to Interest Expense	- -	- -	- -	140.75	-194.95	-213.19	-25.67	-1,810.25	-9,302.31	-2,742.47	-8.75	-16.83
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-111.49	-1,769.96	-8.5	25.17	0.23	-7.88	-19.13	-1,034.91	-3,454.31	-55,689.38	-101,950.81	-231,939.98
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	2.8	- -	4	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	-82.36	- -	-0.33	- -	-0.08	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	2.4	- -	3.38	- -	46.01	- -	- -
Total Debt/Equity (%)	- -	-67.6	7.11	11.36	- -	5.8	3.57	7.83	5.29	-20.32	-9.12	- -
Total Debt/Capital (%)	- -	-28.71	-356.59	27.44	- -	-170.69	-14.72	-0.64	-0.11	-0.16	-0.08	- -
Total Debt/Total Assets (%)	- -	394.79	6.63	9.52	- -	4.97	2.45	6.63	3.74	89.35	84.12	- -
Net Debt to Equity	-95.25	-50.48	-0.08	11.27	-0.17	-0.11	-2.64	-14.8	-1.2	0.15	0.16	1.06
Net Debt/Capital (%)	45.37	-19.98	0.92	27.28	-153.33	3.25	9.82	1.2	0.02	- -	- -	0.01
EBITDA	- -	- -	- -	1	- -	- -	- -	-8	-16	-9	- -	- -
EBITDA-CapEx	- -	- -	- -	1	- -	- -	- -	-8	-16	-9	- -	- -
Operating Income (Loss)	- -	- -	- -	1	- -	- -	- -	-8	-16	-9	- -	- -

Liquidity (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	33.06	0.15	1	- -	0.01	0.01	0.06	1.04	0.03	- -	- -	0.01
Current Ratio	35.71	0.15	14.83	6.14	5.46	7.88	3.12	7.71	3.27	0.01	0.02	0.04
Quick Ratio	33.06	0.15	1	- -	0.01	0.01	0.06	7.56	3.2	- -	- -	0.01
CFO/Avg Current Liab	- -	-3.83	-17.06	-1.01	0.37	-0.39	-0.94	1.48	-1.01	-0.06	-0.12	-0.54
Common Equity/Total Assets	-111.49	-1,769.96	-8.5	25.17	0.23	-7.88	-19.13	-1,034.91	-3,454.31	-55,689.38	-101,950.81	-231,939.98
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	2.8	- -	4	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	-82.36	- -	-0.33	- -	-0.08	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	2.4	- -	3.38	- -	46.01	- -	- -
Total Debt/Equity (%)	- -	-67.6	7.11	11.36	- -	5.8	3.57	7.83	5.29	-20.32	-9.12	- -
Total Debt/Capital (%)	- -	-28.71	-356.59	27.44	- -	-170.69	-14.72	-0.64	-0.11	-0.16	-0.08	- -
Total Debt/Total Assets (%)	- -	394.79	6.63	9.52	- -	4.97	2.45	6.63	3.74	89.35	84.12	- -
CFO/Total Liabilities	-5,921.21	-200.52	-1,252.99	-58.34	40.7	-44.6	-63.89	255.04	-73.33	-4.9	-11.22	-48.95
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-6.46	-114.43	1.8	7.86	0.82	-0.48	0.72	1,234.39	683.16	-1,271.32	-1,445.83	-3,322.11

Working Capital (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	4.01	1.07	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	91.14	342.69	- -	- -	- -
Inventory Turnover	- -	- -	- -	12.53	1.1	0.19	0.58	2	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	29.14	330.46	1,949.89	627.22	182.5	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	115.82	2,105.08	89.36	- -	24.21	- -	10.08	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	3.15	0.17	4.08	- -	15.07	- -	36.21	- -	- -	- -
Cash Conversion Cycle	- -	- -	-3.15	28.97	326.38	- -	612.14	- -	306.48	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	-29.14	-330.46	-1,949.89	-627.22	-91.36	342.69	- -	- -	- -
Inventories	- -	- -	- -	1	1	1	1	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	1	1	1	1	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	- -	- -	- -	- -	250	270	6	- -	- -
- Cash & Cash Equivalents	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	250	270	6	- -	- -
Total Capital	- -	- -	- -	1	- -	- -	- -	-8	-24	-33	-33	-33
Total Debt/Capital (%)	- -	-28.71	-356.59	27.44	- -	-170.69	-14.72	-0.64	-0.11	-0.16	-0.08	- -
Total Debt / EV	- -	1.34	-84.41	1.01	- -	1.02	3.84	- -	- -	0.01	0.31	- -
EV/Sales	- -	- -	- -	0.02	- -	0.23	0.01	209.02	410.34	- -	- -	- -
EV/EBITDA	- -	- -	- -	0.27	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	0.27	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	824.5	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	824.5	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	250	270	6	- -	- -
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	250	270	6	- -	- -
EV per Share	- -	- -	- -	- -	- -	- -	- -	4.65	4.5	0.11	- -	- -
TTM Sales	- -	- -	1	8	1	- -	1	1	1	- -	- -	- -
TTM EBITDA	- -	- -	- -	1	- -	- -	- -	-8	-16	-9	- -	- -
TTM Operating Income	- -	- -	- -	1	- -	- -	- -	-8	-16	-9	- -	- -
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Multiples (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	836.36	-1,832.03	-408.16	-1.64	- -
EV/EBIT	- -	- -	- -	0.27	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	250	270	6	- -	- -
Low Price	- -	- -	- -	- -	- -	- -	- -	1.01	2.14	0.1	- -	- -
EV/Sales	- -	- -	- -	0.02	- -	0.23	0.01	209.02	410.34	- -	- -	- -
EV/EBITDA	- -	- -	- -	0.27	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	-24.32	-15.75	-18.37	-1.42	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	-48.96	-18.16	-30.68	-1.42	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	-7.06	-8.1	-0.72	-0.99	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	-31.78	-11.38	-0.19	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	-23.77	-10.52	-4.97	- -	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	-47.85	-12.14	-8.3	- -	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	-6.9	-5.41	-0.19	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	388.92	555.52	-24.53	-0.2	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	290.81	513.83	-629.36	-0.2	- -
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	585.47	592.56	-1,051.26	-0.2	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	84.48	264.18	-24.53	-0.14	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	209.06	410.31	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	156.32	379.52	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	314.72	437.66	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	45.41	195.13	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	836.36	-1,832.03	-408.16	-1.64	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	625.38	-1,694.55	-10,472.26	-1.63	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	1,259.03	-1,954.16	-17,492.49	-1.64	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	181.66	-871.23	-408.16	-1.15	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	625.38	-1,694.55	-10,472.26	-1.63	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	1,259.03	-1,954.16	-17,492.49	-1.64	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	181.66	-871.23	-408.16	-1.15	- -
EV/Sales Average	- -	- -	- -	0.02	- -	0.23	0.01	156.29	379.55	- -	- -	- -
EV/Sales High	- -	- -	- -	0.02	- -	0.23	0.01	314.68	437.69	- -	- -	- -
EV/Sales Low	- -	- -	- -	0.02	- -	0.23	0.01	45.37	195.16	- -	- -	- -
EV/EBITDA Average	0.57	-0.17	0.19	0.27	- -	-0.11	-0.05	-24.33	-15.75	-18.4	-2.27	0.03
EV/EBITDA High	0.57	-0.17	0.19	0.27	- -	-0.11	-0.05	-48.98	-18.16	-30.74	-2.28	0.03
EV/EBITDA Low	0.57	-0.17	0.19	0.27	- -	-0.11	-0.05	-7.06	-8.1	-0.72	-1.8	0.03
EV/EBIT Average	0.57	-0.17	0.19	0.27	- -	-0.11	-0.05	-24.33	-15.75	-18.4	-2.27	0.03
EV/EBIT High	0.57	-0.17	0.19	0.27	- -	-0.11	-0.05	-48.98	-18.16	-30.74	-2.28	0.03
EV/EBIT Low	0.57	-0.17	0.19	0.27	- -	-0.11	-0.05	-7.06	-8.1	-0.72	-1.8	0.03
Last Price	- -	- -	- -	- -	- -	- -	- -	4.65	4.5	0.1	- -	0.02
High Price	- -	- -	- -	- -	- -	- -	- -	7	4.8	4.5	- -	4
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	187	250	162	- -	- -
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	377	288	270	- -	- -
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	54	129	6	- -	- -

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	47	47	48	48	48	48	48	60	60	60	60	60
Diluted Weighted Avg Shares	47	47	47	48	48	48	48	54	60	60	60	- -
Basic Weighted Avg Shares	47	47	47	48	48	48	48	54	60	60	60	- -
Revenue per Share	- -	- -	0.01	0.17	0.03	- -	0.01	0.02	0.01	- -	- -	- -
EBITDA per Share	- -	- -	- -	0.01	-0.01	-0.01	- -	-0.14	-0.26	-0.15	- -	- -
Operating Income per Share	- -	- -	- -	0.01	-0.01	-0.01	- -	-0.14	-0.26	-0.15	- -	- -
Basic EPS, GAAP	- -	- -	- -	0.01	-0.01	-0.01	- -	-0.14	-0.26	-0.15	- -	- -
Basic EPS from Cont Ops	- -	- -	- -	0.01	-0.01	-0.01	- -	-0.14	-0.26	-0.15	- -	- -
Diluted EPS, GAAP	- -	- -	- -	0.01	-0.01	-0.01	- -	-0.14	-0.26	-0.15	- -	- -
Diluted EPS from Cont Ops	- -	- -	- -	0.01	-0.01	-0.01	- -	-0.14	-0.26	-0.15	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	- -	-0.01	- -	- -	- -	- -	0.01	- -	- -	- -	- -
Free Cash Flow per Basic Share	- -	- -	-0.01	- -	- -	- -	- -	0.01	- -	- -	- -	- -
Cash & Equivalents per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	- -	- -	- -	0.01	- -	- -	- -	-0.15	-0.4	-0.54	-0.54	- -
Tangible Book Value per Share	- -	- -	0.01	0.03	0.02	0.02	0.01	0.01	0.01	- -	- -	- -

Acro Biomedical Co., Ltd.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)